With a short window for product exclusivity and patent protection, pharmaceutical companies today must bring innovative new drugs to market as fast as possible. While moving very quickly, pharmaceutical companies must exercise complete control of their processes because they operate under strict rules on clinical trials, drug approvals, and regulatory compliance.
Armanta technology offers firms ways to achieve:
Faster Time to Market
Integrated data management and delivery
Management of regulatory compliance content and processes
Built on open standards providing ease of integration, scalability, reliability and security
New Drug Data Analysis and Management
Analytical data testing and management
Real-time “Sandbox” modeling to support analytical testing
Flexible UI to support heterogeneous networks
Data Quality and Analysis
Best-of-breed Business Intelligence (BI) engine
High volume, real-time data analysis
Flexible reporting engine
"Armanta is unique in the market. It has grown into more of a solution, but without losing its flexibility."
Hans Lanslots, CTO
APG Investment US Inc, a wholly owned US subsidiary of APG Algemene Pensioen Groep NV,
a Netherlands based company that manages all assets of Stichting Pensioenfonds ABP
one of the largest pension funds in the world.
